Hepatic safety and tolerability of raltegravir among HIV patients coinfected with hepatitis B and/or C
about
Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort.Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Co-Infection Among HIV Infected Individuals at Tertiary Care Hospital in Western Nepal.HIV-hepatitis B virus co-infection: epidemiology, pathogenesis, and treatment.A safety evaluation of raltegravir for the treatment of HIV.
P2860
Hepatic safety and tolerability of raltegravir among HIV patients coinfected with hepatitis B and/or C
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Hepatic safety and tolerabilit ...... cted with hepatitis B and/or C
@ast
Hepatic safety and tolerabilit ...... cted with hepatitis B and/or C
@en
type
label
Hepatic safety and tolerabilit ...... cted with hepatitis B and/or C
@ast
Hepatic safety and tolerabilit ...... cted with hepatitis B and/or C
@en
prefLabel
Hepatic safety and tolerabilit ...... cted with hepatitis B and/or C
@ast
Hepatic safety and tolerabilit ...... cted with hepatitis B and/or C
@en
P2860
P356
P1433
P1476
Hepatic safety and tolerabilit ...... cted with hepatitis B and/or C
@en
P2093
Christopher B Hurt
Richard D Moore
P2860
P304
P356
10.3851/IMP2738
P577
2014-01-23T00:00:00Z